These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma. Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442 [TBL] [Abstract][Full Text] [Related]
4. Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes. Arsa L; Siripoon T; Trachu N; Foyhirun S; Pangpunyakulchai D; Sanpapant S; Jinawath N; Pattaranutaporn P; Jinawath A; Ngamphaiboon N BMC Cancer; 2021 May; 21(1):504. PubMed ID: 33957888 [TBL] [Abstract][Full Text] [Related]
5. Outcomes after primary intensity-modulated radiation therapy for oropharyngeal squamous cell carcinoma at a New Zealand regional cancer centre: Impact of p16 status. Maqsood S; Jameson MB; De Groot C; Hartopeanu C; Yasin NABHM; Thotathil Z Cancer Rep (Hoboken); 2018 Jun; 1(1):e1001. PubMed ID: 32729235 [TBL] [Abstract][Full Text] [Related]
6. HPV status and second primary tumours in oropharyngeal squamous cell carcinoma. Xu CC; Biron VL; Puttagunta L; Seikaly H J Otolaryngol Head Neck Surg; 2013 May; 42(1):36. PubMed ID: 23718873 [TBL] [Abstract][Full Text] [Related]
7. Systematic Review of Second Primary Oropharyngeal Cancers in Patients With p16+ Oropharyngeal Cancer. Bollig CA; Lee DS; Mazul AL; Stepan K; Puram SV; Massa ST; Zenga J; Faden DL; Doering MM; Jackson RS; Pipkorn P Otolaryngol Head Neck Surg; 2021 Apr; 164(4):733-740. PubMed ID: 32928026 [TBL] [Abstract][Full Text] [Related]
8. Oropharyngeal squamous cell carcinoma: p16/p53 immunohistochemistry as a strong predictor of HPV tumour status. Benzerdjeb N; Tantot J; Blanchet C; Philouze P; Mekki Y; Lopez J; Devouassoux-Shisheboran M Histopathology; 2021 Sep; 79(3):381-390. PubMed ID: 33560536 [TBL] [Abstract][Full Text] [Related]
9. Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults. Windon MJ; D'Souza G; Rettig EM; Westra WH; van Zante A; Wang SJ; Ryan WR; Mydlarz WK; Ha PK; Miles BA; Koch W; Gourin C; Eisele DW; Fakhry C Cancer; 2018 Jul; 124(14):2993-2999. PubMed ID: 29710393 [TBL] [Abstract][Full Text] [Related]
10. Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality? Fischer CA; Zlobec I; Green E; Probst S; Storck C; Lugli A; Tornillo L; Wolfensberger M; Terracciano LM Int J Cancer; 2010 Mar; 126(5):1256-62. PubMed ID: 19697324 [TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma. Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365 [TBL] [Abstract][Full Text] [Related]
12. The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy. Morbini P; Alberizzi P; Ferrario G; Capello G; De Silvestri A; Pedrazzoli P; Tinelli C; Benazzo M Acta Otorhinolaryngol Ital; 2019 Feb; 39(1):9-17. PubMed ID: 30936574 [TBL] [Abstract][Full Text] [Related]
13. Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&E Stains. Klein S; Quaas A; Quantius J; Löser H; Meinel J; Peifer M; Wagner S; Gattenlöhner S; Wittekindt C; von Knebel Doeberitz M; Prigge ES; Langer C; Noh KW; Maltseva M; Reinhardt HC; Büttner R; Klussmann JP; Wuerdemann N Clin Cancer Res; 2021 Feb; 27(4):1131-1138. PubMed ID: 33262137 [TBL] [Abstract][Full Text] [Related]
14. The value of p16 and HPV DNA in non-tonsillar, non-base of tongue oropharyngeal cancer. Hammarstedt L; Holzhauser S; Zupancic M; Kapoulitsa F; Ursu RG; Ramqvist T; Haeggblom L; Näsman A; Dalianis T; Marklund L Acta Otolaryngol; 2021 Jan; 141(1):89-94. PubMed ID: 32940116 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma. Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing. Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466 [TBL] [Abstract][Full Text] [Related]
18. Survival of patients with oropharyngeal squamous cell carcinomas (OPSCC) in relation to TNM 8 - Risk of incorrect downstaging of HPV-mediated non-tonsillar, non-base of tongue carcinomas. Marklund L; Holzhauser S; de Flon C; Zupancic M; Landin D; Kolev A; Haeggblom L; Munck-Wikland E; Hammarstedt-Nordenvall L; Dalianis T; Näsman A Eur J Cancer; 2020 Nov; 139():192-200. PubMed ID: 32951963 [TBL] [Abstract][Full Text] [Related]
19. p16 overexpression and Rb loss correlate with high-risk HPV infection in oropharyngeal squamous cell carcinoma. Jiromaru R; Yamamoto H; Yasumatsu R; Hongo T; Nozaki Y; Nakano T; Hashimoto K; Nakagawa T; Oda Y Histopathology; 2021 Sep; 79(3):358-369. PubMed ID: 33450095 [TBL] [Abstract][Full Text] [Related]